Global Antimicrobial Peptides Industry Research Report, Growth Trends and Competitive Analysis 2021-2027

SKU ID : QYR- 18353820

Publishing Date : 26-May-2021

No. of pages : 116

PRICE
5600
8400
11200

  • Antimicrobial peptides (AMPs), also called host defense peptides (HDPs) are part of the innate immune response found among all classes of life. Fundamental differences exist between prokaryotic and eukaryotic cells that may represent targets for antimicrobial peptides. These peptides are potent, broad spectrum antibiotics which demonstrate potential as novel therapeutic agents. Antimicrobial peptides have been demonstrated to kill Gram negative and Gram positive bacteria, enveloped viruses, fungi and even transformed or cancerous cells. Unlike the majority of conventional antibiotics it appears that antimicrobial peptides frequently destabilize biological membranes, can form transmembrane channels, and may also have the ability to enhance immunity by functioning as immunomodulators.
    The major players in the industry are AnaSpec, AMP Biotech, Phoenix Biotech and Novabiotics, with revenues of about 7%, 9%, 3% and about 26% respectively in 2019.
    By region, North America had the highest share of sales, at about 35%.

    In 2020, the global Antimicrobial Peptides market size was US$ 5 million and is forecast to 6 million US in 2027, growing at a CAGR of 5.4% during the 2021-2027. In this study, 2020 has been considered as the base year and 2021 to 2027 as the forecast period to estimate the market size for Antimicrobial Peptides.
    The market research report offered here is a very useful resource that can help manufacturers, stakeholders, decision-makers, and other market participants to become familiar with every factor impacting the growth of the global Antimicrobial Peptides market. The analysts authoring the report have closely studied key strategies adopted by top players of the global Antimicrobial Peptides market. The report includes SWOT, and other market analyses to provide a clear and deep understanding of important aspects of the global Antimicrobial Peptides market. Readers of the report can become informed about current and future trends of the global Antimicrobial Peptides market and how they will impact market growth during the forecast period.

    By Region
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Philippines
    Vietnam
    Latin America
    Mexico
    Brazil
    Argentina
    Middle East & Africa
    Turkey
    Saudi Arabia
    U.A.E

    Segment by Type
    Plant Antimicrobial Peptides
    Microbial Antimicrobial Peptides
    Animal Antimicrobial Peptides

    Segment by Application
    Pharmaceuticals
    Feed Additives
    Others

    By Company
    AnaSpec
    AMP Biotech
    Phoenix Biotech
    Novabiotics
    Chinese Peptide
    Ontores
    GenScript
    Hycult Biotech
    Sunsmile
    Ruixing Biotechnology
    Zhongnong Yingtai Biotechnology
    Glam Technology
    ProteLight Pharmaceutical & Biotechnology

    Frequently Asked Questions



    This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.

    • By product type
    • By End User/Applications
    • By Technology
    • By Region

    The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
    market Reports market Reports